SOTIO Biotech, a Czech clinical-stage biopharma owned by PPF Group, today announced the promotion of Dr Vivi Boura, an ...

George Tidmarsh has resigned as director of the US Food and Drug Administration’s Center for Drug Evaluation and Research ...

Canadian infection control company Ondine Biomedical (AIM: OBI) is expanding its Steriwave nasal photodisinfection platform ...

The rulebook for rare disease treatments will be overhauled to make it quicker and easier to get these therapies tested, ...

India’s GLP-1 drug market is poised for explosive growth, outpacing global trends and positioning domestic pharma giants to ...

Swiss pharma major Roche (ROG: SIX) has reported positive Phase III data for Gazyva (obinutuzumab) in systemic lupus ...

UK-based specialty CNS-focused pharma company CNX Therapeutics says it has acquired the global Sativex (nabiximols) business ...

Germany-based Immatics has this month announced updated clinical data from its PRAME-directed TCR T-cell therapy, anzu-cel (anzutresgene autoleucel, IMA203), in 16 patients with metastatic uveal ...

Pfizer today announced that it has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk in the US District Court for the District of Delaware.

The pharmaceutical industry is experiencing a seismic shift in regulatory transparency as the US Food and Drug Administration (FDA) implements its most ambitious disclosure initiative to date.

Pharmacovigilance (PV) is a crucial process used by pharmaceutical companies, healthcare professionals and regulators in identifying, evaluating and preventing adverse drug reactions.

Irish healthcare group Uniphar (LSE: UPR) has unified its US businesses under one banner, rebranding RRD Biopharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs as Uniphar ...